This underscores a close relationship between the p53 signaling pathway, AEC senescence, and progressive disease in IPF, suggesting the need for a stratified approach to patient management based on the molecular signature of lung tissue. The gene discussed is TP53; the disease is idiopathic pulmonary fibrosis.